LARS anticorps (N-Term)
Aperçu rapide pour LARS anticorps (N-Term) (ABIN953139)
Antigène
Voir toutes LARS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 183-213, N-Term
-
Specificité
- This antibody recognizes Human and Mouse LARS (N-term).
-
Purification
- Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogène
- KLH conjugated synthetic peptide between 183-213 amino acids from the N-terminal region of Human LARS.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Autre désignation
- LARS
-
Sujet
- This gene encodes a cytosolic leucine-tRNA synthetase, a member of the class I aminoacyl-tRNA synthetase family. The encoded enzyme catalyzes the ATP-dependent ligation of L-leucine to tRNA(Leu). It is found in the cytoplasm as part of a multisynthetase complex and interacts with the arginine tRNA synthetase through its C-terminal domain. Alternatively spliced transcript variants of this gene have been found, however, their full-length nature is not known.Synonyms: EC=6.1.1.4, KIAA1352, LARS, LeuRS, Leucine-tRNA ligase, Leucyl-tRNA synthetase, cytoplasmic
-
Poids moléculaire
- 134466 Da
-
ID gène
- 51520
-
NCBI Accession
- NP_064502
-
Pathways
- EGFR Signaling Pathway
Antigène
-